Cell lethality induced by PARP inhibitors in PEO1 HR-deficient ovarian cancer cells40 was also reversed by DRB, whereas HR-proficient PEO4 ovarian cancer cells, derived from the same cancer as the PEO1 cells40, were resistant to PARP inhibitors (Extended Data Fig. 7e,f). This evidence concerns the gene PARP1 and cancer.